Moreover, several ceramide metabolites could enhance 1,25(OH)D-induced differentiation through the involvement of the PI3-K/PKC/JNK/ERK pathways, as seen in HL-60 human leukemia cellular models [52]. This evidence concerns the gene PRRT2 and leukemia.